FINVX | RRIGX | FINVX / RRIGX | |
Total Expense Ratio | 0.01 | 1.33 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 1.33 | 1% |
Fund Existence | 16 years | 23 years | - |
Gain YTD | 25.839 | 23.905 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.9B | 15.2B | 105% |
Annual Yield % from dividends | 3.73 | 1.72 | 216% |
Returns for 1 year | 23.93 | 23.96 | 100% |
Returns for 3 years | 71.34 | 63.27 | 113% |
Returns for 5 years | 117.63 | 95.76 | 123% |
Returns for 10 years | 82.21 | 61.94 | 133% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PTNQ | 69.87 | 0.09 | +0.13% |
Pacer Trendpilot™ 100 ETF | |||
NUMG | 47.43 | -0.24 | -0.50% |
Nuveen ESG Mid-Cap Growth ETF | |||
SPHQ | 69.96 | -0.57 | -0.81% |
Invesco S&P 500® Quality ETF | |||
RSPM | 32.10 | -0.33 | -1.02% |
Invesco S&P 500® Equal Weight Matrls ETF | |||
BIB | 45.94 | -0.60 | -1.29% |
ProShares Ultra Nasdaq Biotechnology |